New Horizon Biotech

company

About

New Horizon Biotech (NHB) produces a Single Use Horizontal Fermentation system (SUHF™) for improved operations of microbial fermentation.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$256K
Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

- Next-Gen Fermentors For Next-Gen Business Needs -
New Horizon Biotechnologies (NHB) is currently concluding testing of its patented Single Use Horizontal Fermentor system (SUHF™). These studies demonstrate the effectiveness of the system for single-use microbial fermentation and compares and contrasts it with legacy designs currently in use. Microbial fermentation is the basis for the production of a wide range of high value biopharmaceutical products, including antibiotics, vaccines, and therapeutic proteins. NHB intends to deliver production and operational cost savings and efficiencies with its new SUHF™ system that will fundamentally improve the global competitive edge of its users.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$256K
New Horizon Biotech has raised a total of $256K in funding over 2 rounds. Their latest funding was raised on Mar 31, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 31, 2021 Grant $256K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
New Horizon Biotech is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant